Literature DB >> 16542374

A novel model of acute liver injury in mice induced by T cell-mediated immune response to lactosylated bovine serum albumin.

Ling Xu1, Ying Zhao, Yu Qin, Qiang Xu.   

Abstract

The present study aimed to establish a murine liver injury model with T cell-mediated immune response to mimic the cellular immunological pathogenesis of hepatitis. Bovine serum albumin was conjugated with lactose by redox to prepare lactosylated bovine serum albumin (LacBSA). The liver injury was induced in C57BL/6 mice by a T cell-mediated immune response to LacBSA. After a systemic injection of LacBSA, which elicited immune response in mice sensitized twice with LacBSA, liver injury was observed with obvious increase of aminotransferase levels in serum and hepatocelluar damage in liver histology. However, the splenectomy before the elicitation significantly alleviated the liver injury. Direct contact between spleen T cells/nonparenchymal cells and hepatocytes was proved to be essential to induce the release of alanine aminotransferase in the culture supernatant. In addition, both levels of Fas mRNA in liver tissues and Fas Ligand in spleen cells were up-regulated at 6 h after the elicitation. The Fas mRNA expression was maintained in a relatively high level at 18 h while Fas Ligand began to decrease after 12 h. These results demonstrated that the T cell immune response to LacBSA could be successfully localized in the liver to induce an immunological liver injury in mice. The pathogenesis of the liver injury might involve the interaction between the liver-infiltrating lymphocytes and hepatocytes through Fas/FasL pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542374      PMCID: PMC1809629          DOI: 10.1111/j.1365-2249.2006.03034.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

Review 1.  Cell-specific delivery of genes with glycosylated carriers.

Authors:  M Hashida; M Nishikawa; F Yamashita; Y Takakura
Journal:  Adv Drug Deliv Rev       Date:  2001-11-19       Impact factor: 15.470

2.  Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.

Authors:  Simona Urbani; Carolina Boni; Barbara Amadei; Paola Fisicaro; Simona Cerioni; Maria Antonietta Valli; Gabriele Missale; Carlo Ferrari
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

3.  Effect of diphenyl dimethyl bicarboxylate on concanavalin A-induced liver injury in mice.

Authors:  Mei Gao; Jianjun Zhang; Gengtao Liu
Journal:  Liver Int       Date:  2005-08       Impact factor: 5.828

4.  The fas and fas ligand pathways in liver allograft tolerance.

Authors:  T L Pan; S Goto; Y C Lin; R Lord; K C Chiang; C Y Lai; Y S Chen; H L Eng; Y F Cheng; T Tatsuma; S Kitano; C L Lin; C L Chen
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

5.  Rescue of in vivo FAS-induced apoptosis of hepatocytes by corticosteroids either associated with alcohol consumption by mice or provided exogenously.

Authors:  Laura Sosa; Debbie Vidlak; Jennifer M Strachota; Jackie Pavlik; Thomas R Jerrells
Journal:  Int Immunopharmacol       Date:  2005-02       Impact factor: 4.932

6.  Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.

Authors:  Wook-Hwan Kim; Kunio Matsumoto; Kazuhiko Bessho; Toshikazu Nakamura
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

7.  Liver injury model induced in mice by a cellular immunologic mechanism--study for use in immunopharmacological evaluations.

Authors:  Q Xu; J Lu; R Wang; F Wu; J Cao; X Chen
Journal:  Pharmacol Res       Date:  1997-04       Impact factor: 7.658

8.  Establishment of a T cell-dependent nude mouse liver injury model induced by Propionibacterium acnes and LPS.

Authors:  Y Tanaka; A Takahashi; K Kobayashi; I Arai; S Higuchi; S Otomo; K Watanabe; S Habu; T Nishimura
Journal:  J Immunol Methods       Date:  1995-05-11       Impact factor: 2.303

9.  Liver injury model in mice induced by a cellular immunologic mechanism--delayed-type hypersensitivity-induced liver injury to picryl chloride and phenotype of effector cell.

Authors:  Q Xu; R Wang; J Jiang; F Wu; J Lu; P K Tan; L Xu
Journal:  Cell Immunol       Date:  1996-01-10       Impact factor: 4.868

10.  Advances in immunomodulating therapy of HBV infection.

Authors:  Chee-Kin Hui; George Kk Lau
Journal:  Int J Med Sci       Date:  2005-01-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.